Metabolic Syndrome and tepressive Symptoms in a Primary Health Care Setting in Turkey

Basit Öğe Kaydı
dc.contributor.authorDemirci, Hakan
dc.contributor.authorCinar, Yildirim
dc.contributor.authorBilgel, Nazan
dc.date.accessioned2024-06-12T11:08:23Z
dc.date.available2024-06-12T11:08:23Z
dc.date.issued2011
dc.departmentTrakya Üniversitesien_US
dc.description.abstractBackground: The possible association between depressive symptoms and metabolic syndrome (MetS) has recently become an important topic of discussion. There is some limited and inconsistent evidence in the literature concerning whether or not depression and metabolic syndrome are associated. The aim of this study was to examine the association between depressive symptoms and metabolic syndrome. Methods: This is a cross-sectional community-based study. The setting is a family practice unit in an urban area which serves about 3,600 people. The participants were 250 individuals aged 18 and over, selected randomly from all enrolled patients in this family practice unit. National Cholesterol Education Program (NCEP- ATP-III) criteria were used for the classification of metabolic myndrome (MetS). The Beck Depression Inventory was filled out by the participants for the evaluation of depressive symptoms. Results: The prevalence of MetS was similar for men (48.8%) and women (48.1%) and increased with age in both sexes. Participants with only primary education were found to be 2.2 times more at risk of developing MetS than participants with a higher education. The prevalence of depressive symptoms was higher among women (31.0%) than men (9.9%). Statistical analyses revealed no statistically significant association between MetS and depressive symptoms. Conclusion: The prevalence of MetS was found to be high in both sexes. Women had a 3.8 times higher risk of developing depressive symptoms than men. We found no association of depressive symptoms with MetS or with any of the MetS criteria.en_US
dc.identifier.endpage57en_US
dc.identifier.issn1017-7833
dc.identifier.issue1en_US
dc.identifier.startpage49en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/22403
dc.identifier.volume21en_US
dc.identifier.wosWOS:000290364100008en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherKure Iletisim Grubu A Sen_US
dc.relation.ispartofKlinik Psikofarmakoloji Bulteni-Bulletin Of Clinical Psychopharmacologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMetabolic Syndromeen_US
dc.subjectAdult Populationen_US
dc.subjectDepressive Symptomsen_US
dc.subjectFamily Practiceen_US
dc.subjectTurkeyen_US
dc.subjectDepressive Symptomsen_US
dc.subjectCholesterol Levelsen_US
dc.subjectYoung-Adultsen_US
dc.subjectOlder Menen_US
dc.subjectAssociationen_US
dc.subjectRisken_US
dc.subjectAnxietyen_US
dc.subjectCooccurrenceen_US
dc.subjectPrevalenceen_US
dc.subjectObesityen_US
dc.titleMetabolic Syndrome and tepressive Symptoms in a Primary Health Care Setting in Turkeyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu